Which NSAID is suggested as potentially least harmful for OA patients with cardiovascular concerns?

Which NSAID is suggested as potentially least harmful for OA patients with cardiovascular concerns?

• A. Naproxen
• B. Low-dose aspirin
• C. Ibuprofen
• D. Celecoxib

Answer: (A)

The main idea is that not all NSAIDs carry the same cardiovascular risk, so one that tends to be safer for patients with heart concerns is preferred. Naproxen is viewed as having the lowest cardiovascular risk among common NSAIDs used for osteoarthritis, meaning it is less likely to trigger events like heart attack or stroke compared with others such as diclofenac, ibuprofen, or COX-2 inhibitors. This relative safety is thought to arise from its pharmacologic effects, which don’t tilt the thromboxane–prostacyclin balance toward a pro-thrombotic state as strongly as some alternatives do, and it tends to cause less blood pressure elevation than ibuprofen or diclofenac. Celecoxib, a COX-2 inhibitor, has shown cardiovascular risk signals at higher doses, while ibuprofen and diclofenac are more consistently associated with adverse cardiovascular effects. Low-dose aspirin is primarily a cardiovascular protective agent, not an OA pain medicine, and combining it with NSAIDs can raise GI risk and complicate antiplatelet effects, so it isn’t chosen for OA pain relief. However, all NSAIDs can affect blood pressure, kidney function, and fluid balance, so they should be used at the lowest effective dose for the shortest duration with careful monitoring in patients with cardiovascular concerns.

The main idea is that not all NSAIDs carry the same cardiovascular risk, so one that tends to be safer for patients with heart concerns is preferred. Naproxen is viewed as having the lowest cardiovascular risk among common NSAIDs used for osteoarthritis, meaning it is less likely to trigger events like heart attack or stroke compared with others such as diclofenac, ibuprofen, or COX-2 inhibitors. This relative safety is thought to arise from its pharmacologic effects, which don’t tilt the thromboxane–prostacyclin balance toward a pro-thrombotic state as strongly as some alternatives do, and it tends to cause less blood pressure elevation than ibuprofen or diclofenac. Celecoxib, a COX-2 inhibitor, has shown cardiovascular risk signals at higher doses, while ibuprofen and diclofenac are more consistently associated with adverse cardiovascular effects. Low-dose aspirin is primarily a cardiovascular protective agent, not an OA pain medicine, and combining it with NSAIDs can raise GI risk and complicate antiplatelet effects, so it isn’t chosen for OA pain relief. However, all NSAIDs can affect blood pressure, kidney function, and fluid balance, so they should be used at the lowest effective dose for the shortest duration with careful monitoring in patients with cardiovascular concerns.